STOCK TITAN

Plexus picks Michael V. Schrock as chair if reelected

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

PLEXUS CORP. (PLXS) announced a Board leadership transition. Dean A. Foate, Chair of the Board, will continue as a director and Chair until the conclusion of the 2027 Annual Meeting of Shareholders, when his Board service will end after he chose not to stand for reelection. The Board selected current director Michael V. Schrock to succeed him as Chair effective at the meeting’s conclusion, subject to Schrock’s reelection by shareholders. The Board also approved reducing its size from ten to nine directors, effective at that time. Foate’s decision is personal and is not the result of a disagreement with the Company, its management or the Board.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Board size from 10 to 9 directors Approved reduction effective at the conclusion of the 2027 Annual Meeting

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will PLXS Chair Dean A. Foate leave the board?

Dean A. Foate will leave the Board at the conclusion of the 2027 Annual Meeting, after continuing as a director and Chair until then.

Who is set to succeed PLXS Chair Dean A. Foate?

The Board selected current director Michael V. Schrock to succeed Foate as Chair at the conclusion of the 2027 Annual Meeting, subject to Schrock’s reelection to the Board by shareholders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0000785786false00007857862026-11-182026-11-18

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________________________________________________________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
____________________________________________________________________________________________________________________________________
Date of Report (Date of earliest event reported): November 18, 2026
____________________________________________________________________________________________________________________________________
plxslogo8ka05.gif
PLEXUS CORP.
(Exact name of registrant as specified in its charter)
____________________________________________________________________________________________________________________________________
Wisconsin001-1442339-1344447
(State or other jurisdiction
 of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
One Plexus Way
Neenah, Wisconsin 54956
(Address of principal executive offices) (Zip Code)
Telephone Number (920) 969-6000
(Registrant’s telephone number, including Area Code) 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, $0.01 par valuePLXSThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company    ☐
        If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐



Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 18, 2026, Dean A. Foate, Chair of the Board of Directors (the “Board”) of Plexus Corp. (the “Company”), notified the Company of his decision not to stand for reelection to the Board at the Company’s 2027 Annual Meeting of Shareholders (the “2027 Annual Meeting”). Mr. Foate will continue to serve as a director and Chair of the Board until the conclusion of the 2027 Annual Meeting, at which time his service on the Board will end. Mr. Foate’s decision is a personal one and is not the result of any disagreement with the Company, its management or the Board on any matter relating to the Company’s operations, policies or practices.

The Board has selected Michael V. Schrock, a current member of the Board, to succeed Mr. Foate as Chair of the Board, effective upon the conclusion of the 2027 Annual Meeting, subject to Michael V. Schrock’s reelection to the Board by the Company’s shareholders at the 2027 Annual Meeting.

In connection with Mr. Foate’s decision not to stand for reelection, the Board has approved a reduction in the size of the Board from ten to nine directors, effective as of the conclusion of the 2027 Annual Meeting.

The Board thanks Mr. Foate for his many years of dedicated service and leadership to the Company, including as Chief Executive Officer and, subsequently, as a director and Chair of the Board.

Item 9.01    Financial Statements and Exhibits

(d) The following exhibits are filed herewith:

Exhibit NumberDescription
104Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document)





* * * * *
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 19, 2026PLEXUS CORP.
(Registrant)
By: /s/ Angelo M. Ninivaggi
Angelo M. Ninivaggi
Executive Vice President, Chief Legal and Public Affairs Officer


Filing Exhibits & Attachments

4 documents

Keep reading